Case Studies in Bioethics: Should Patients Have Access to an Unapproved Drug?: Laetrile: Cancer Cure or Quack Remedy?

&
Hastings Center Report 6 (6):18 (1976)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.2307/3561143

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,610

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Off-trial access to experimental cancer agents for the terminally ill: balancing the needs of individuals and society.M. Chahal - 2010 - Journal of Medical Ethics 36 (6):367-370.
Anything to Stay Alive: The Challenges of a Campaign for an Experimental Drug.Nathan Geffen - 2015 - Developing World Bioethics 16 (1):45-54.
The use of patient navigators to improve cancer care for Hispanic patients.Loreley Robie, Daniela Alexandru & Daniela A. Bota - unknown
Bioethics and Cancer: When the Professional Becomes Personal.Rebecca Dresser - 2011 - Hastings Center Report 41 (6):14-18.
Access to Unapproved Medical Interventions in Cases of Catastrophic Illness.Udo Schuklenk - 2014 - American Journal of Bioethics 14 (11):20-22.
Proposal for Patient Obligations for Access to Unapproved Medical Interventions: Both Too Much and Not Enough.Audrey Chapman - 2014 - American Journal of Bioethics 14 (11):25-26.
Case Studies in Bioethics: Drug Treatment or Drug Addiction?Robert F. Murray & Alan Soble - 1974 - Hastings Center Report 4 (3):10.
A Case Report The Understanding of Bioethics: Truth-Telling to Patients of Cancer in Pakistani Perspective.Amir Abdullah - 2015 - Journal of Clinical Research and Bioethics 6 (3).
Special Access Programs Warrant Further Critical Attention: Authors' Response to Open Peer Commentaries on “Ethical Justifications for Access to Unapproved Medical Interventions: An Argument for (Limited) Patient Obligations”.Mary Jean Walker, Wendy A. Rogers & Vikki Entwistle - 2014 - American Journal of Bioethics 14 (11):W1 - W2.
Quack-quack-quack: Donald Duck dissents.John L. Dusseau - 1986 - Perspectives in Biology and Medicine 30 (3):345-354.
Ethics of Continuing to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”.Holly A. Taylor, Ellen Kuwana & Benjamin S. Wilfond - 2014 - American Journal of Bioethics 14 (4):56-56.
Quack, Quack, Quack: The Sellers of Nostrums in Prints, Posters, Ephemera, and Books. [REVIEW]Jennifer Connor - 2003 - Isis 94:516-517.
The Ethical Issues of Terminal Cancer Patients.Wenhao Su - 2006 - Philosophy and Culture 33 (4):5-15.
A Model for Communication About Longshot Treatments in the Context of Early Access to Unapproved, Investigational Drugs.Eline M. Bunnik & Nikkie Aarts - 2018 - American Journal of Bioethics 18 (1):34-36.
The Role of Clinical Equipoise and Practical Considerations in Deciding Whether to Continue to Provide a Drug on an Open-Label Extension Study for an “Unapproved Indication”.Ryan R. Nash - 2014 - American Journal of Bioethics 14 (4):59-60.

Analytics

Added to PP
2018-04-09

Downloads
13 (#1,030,551)

6 months
5 (#625,697)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references